Karin Van Baelen &
Access optionsAccess options
The authors are members of the Charles Forum, founded in 2018 by request of the Hever Group of Pharmaceutical R&D heads to advance the identification, prioritization, and pursuit of progressive and global issues affecting biopharmaceutical industry regulation. Current Charles Forum members include regulatory heads and regulatory policy leads from 12 multinational biopharmaceutical companies. The authors acknowledge the many industry consortia working in partnership with the FDA to advance information exchange through cloud technologies.
Competing Financial Interests
The authors are all employed by multinational biopharmaceutical companies, as indicated in their affiliations.
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.